{"name":"Northern California Retina Vitreous Associates","slug":"northern-california-retina-vitreous-associates","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE1sbFJKVjVRRHlwdXQ5NE8yUG9mVEQ0MG1LVTAydUhLejZ4RU1BcE81cktlN0J5QkJaLVBQSy1jdGllcHpOV0c0cjV1Y0tXTTdQSjR6b3VJYnV5enlwN09keS1Ecmw3UQ?oc=5","date":"2025-10-21","type":"regulatory","source":"MedPage Today","summary":"Mixed but Mostly Promising Results With IL-6 Inhibitor in Uveitic Macular Edema - MedPage Today","headline":"Mixed but Mostly Promising Results With IL-6 Inhibitor in Uveitic Macular Edema","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTE91VWliWWRRMEhWdzI5cTlYaC1BS1EyY0JFYXpNR1ZYQnhCME1WOEZLSWRFZmk3ZFFVckpNc2ZvT29pbGU5N2JqbG5XZUlOT3ZkdHkwN3RwdnpZTFFmeU5JTkYyR1M?oc=5","date":"2025-10-01","type":"pipeline","source":"MedPage Today","summary":"What's on the Horizon for Age-Related Macular Degeneration? - MedPage Today","headline":"What's on the Horizon for Age-Related Macular Degeneration?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOVnNYMnJFaGQ4UlB1ckVpbThqS2xhaENtUFE2NG42WUxhNDdVZDd2bjA2ZUVMbzJjM2xXNEs3UDBxLWJZaFF0VHJjTm5neFdSZ2NyX0ZVeTBRckp6TTB2SFBFcGVFcXpkdU54SUFZWVZwQ0Z1eG5kem1BekdkZHRKWTl3MkRSUFpEaWRPdFMtNmRUYklqcHlMdXhUZzNDYi02RUZ3WERncjc2SHhqTV9TaWJ5dmotcTZDeEtQb2g3NFI?oc=5","date":"2024-10-21","type":"pipeline","source":"Ophthalmology Times","summary":"AAO 2024: New drug shows promise as first to protect vision in patients with dry AMD - Ophthalmology Times","headline":"AAO 2024: New drug shows promise as first to protect vision in patients with dry AMD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPX19fYVJLTTlkdldkaTc4STJpcDFJdGlqdDlEeXljV3BGeGd3UmtsTnBqaVlGbGt2Ty1qbWtoeXg2UzhFRDR1bkhCX0t3VmNJZjgtOXBHSUl2Ykl1WTBTaW5jRUxSNTJzZnBwZThIR29RUUcyWHdsWEMtOEpKd0JvOVJmcndScWJQRzNkWUxKMk9uUQ?oc=5","date":"2024-10-21","type":"pipeline","source":"drugdiscoverytrends.com","summary":"ANX007 cuts vision loss risk by 72% in dry AMD patients - drugdiscoverytrends.com","headline":"ANX007 cuts vision loss risk by 72% in dry AMD patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPdFNwTGZSWFNfa1JwOHlJdFhpVlYyM3RvbnJwSFZDQ1V0eVdWY29OejJQblRsNHhJVURsN01pM29qUkw3RGN6TlEyOVBlUGxJNHRncGRqYjRRS1FDMUN0UllCOURUUmhkd0Nibjk3UlB4WElybVA0Q0JMR0xKdVIwOEtvNU9WSEFjVEszS2w1NDJtM0J3SHpkRzEtMENpOGdfd2xpM1ln?oc=5","date":"2024-09-03","type":"pipeline","source":"BioSpace","summary":"Beyond Rare Disease: Wet AMD Gene Therapy Could Reach Millions - BioSpace","headline":"Beyond Rare Disease: Wet AMD Gene Therapy Could Reach Millions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFB0RXRadEdJcjBERi1SLXd4bnVEWkpHc2ZpYllaT3pUSTBvVmVzeENleHVaczV6Vkd3cnVqdlV4eDhkRVVOQUw2ZE5HREtqWEVvd3FJTzRiZzNlQnZJclFZ?oc=5","date":"2024-04-15","type":"pipeline","source":"Nature","summary":"Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapy - Nature","headline":"Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxPYnRJVUZIbk1rbzZKbXNsMlZ6MVc2TldiaDFzMzJUbEcxQ2hZMEREZ2dfa2d1WGxfYkl2SXpmejN6c1N0NnBZMnJ4UHFXTE41TTl4cDBrVnYtZk1LdEN2YjBGUGNZVDdrRFRQWU1qLTFZM0dDTjlzVGF1NXE5U2ctUkNyVmM5UW9GRldVSkd6cVFwNnpqMnRYQXBLSU9ha0hKU3dFX2RXTlFmMjBTV0Z3QnpjMnp1eGNRZlZfZjNMS1Y3Y0lwdGFxemp2VnF3WlB0UnR1bmx5amg4SjFYZEE?oc=5","date":"2022-12-07","type":"pipeline","source":"Ophthalmology Times","summary":"Verana Health, American Academy of Ophthalmology debut Verana Research Network, an IRIS Registry Initiative - Ophthalmology Times","headline":"Verana Health, American Academy of Ophthalmology debut Verana Research Network, an IRIS Registry Initiative","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE9qNTdyUGMtVUhyMGhBbWNyWW5ucC1DamtuaWY4MEcyTktkaDZ2WlRqZXRXYWdzOG1hYnRvV3Y1VDNjLU5yRjI1SWtfRmlaai1aeXJiZ2gtSHRwOHZmZzZHVGJTbXZkRHAxU2U2U1ROb2g?oc=5","date":"2021-11-01","type":"pipeline","source":"American Academy of Ophthalmology","summary":"Port Delivery System for AMD - American Academy of Ophthalmology","headline":"Port Delivery System for AMD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE43VGRFbFdva1pYdEswajB3YWVmZlA2dGFic0JwQ1FpNVBUdzNJZllzTmczbkRXcGMwOWhuSEhVYUVCODRPYzU2LVQ0MC1PSEVFN2p1RUhBUGp2ZDBwQkRqaHVEc0dRUQ?oc=5","date":"2017-08-15","type":"pipeline","source":"MedPage Today","summary":"Is Syringe Lubricant Causing Floaters After Eye Injection? - MedPage Today","headline":"Is Syringe Lubricant Causing Floaters After Eye Injection?","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}